Oct 14, 2026 | Pharmacy Times

Cemdisiran’s Potential to Reduce Hospitalizations in Myasthenia Gravis

Ali A. Habib, MD, discusses encouraging findings from the NIMBLE trial suggesting investigational cemdisiran may reduce hospitalizations in generalized myasthenia gravis, while emphasizing that small event numbers require cautious interpretation.

Oct 12, 2026 | Managed Healthcare Executive

Neuro-ophthalmologists outline how eye clinicians can recognize and manage headache | AAO 2026

At AAO 2026, UC Irvine ophthalmology professors Sam Spiegel, MD, and Vivek Patel, MD, presented guidelines for eye clinicians to recognize, diagnose and treat migraines using targeted questions, stepwise therapies and awareness of mimics such as trochleitis.

Oct 07, 2026 | Parade

This Common Bathroom Habit Does Not Cause Breast Cancer—Here’s How the Myth Started

Backed by her research findings and clinical expertise, Assistant Professor of Medicine Nellie Nafissi, MD, debunks common myths about breast cancer causes, including the misconception that the use of antiperspirants can cause cancer.

Oct 07, 2026 | New York Post

Southern California surfers are being diagnosed with a bizarre ‘tumor’ condition

Department of Dermatology researchers at UC Irvine identified “liposurfomas,” benign fatty chest growths caused by repetitive prone paddling that are frequently mistaken for cancer in longtime surfers.

Oct 01, 2026 | Irvine Standard

Built for Breakthroughs and Excellence

From pioneering cell therapies for Huntington's disease to developing the first FDA-cleared stem cell treatment for spinal injuries, UC Irvine School of Medicine researchers are driving breakthroughs in neurobiology research.

Sep 30, 2026 | Maeil Business

Development of Electromechanical Reformation (EMR) by U.S. research team

Researchers, including UC Irvine's Brian J.F. Wong, MD, developed Electromechanical Reformation (EMR) technology. This method uses weak electrical stimulation to reshape corneal collagen without laser incisions, offering a potentially safer and more cost-effective vision correction option.

Sep 24, 2026 | The Transmitter

Polarized cortical organoids mimic the brain’s regional organization

A UC Irvine-led study by Momoko Watanabe, PhD, developed cortical organoids that mimic regional organization in the developing human brain, providing a potential model for studying autism and other neurological conditions.

Sep 21, 2026 | Contemporary Pediatrics

Tallie Z. Baram, MD, discusses unpredictable childhood environments and mental health risks

In a study led by UC Irvine's Tallie Baram, MD, she found that childhood unpredictability is a distinct mental health risk factor beyond traditional adverse childhood experiences (ACEs). Adding unpredictability screening can help identify at-risk children who standard ACEs assessments might otherwise miss.

Sep 18, 2026 | Newport Beach Independent

CureDuchenne and UC Irvine Host Screening of “The Remarkable Life of Ibelin” and Panel Discussion Sept. 19 at Rivian South Coast Theater in Laguna Beach

CureDuchenne and UC Irvine hosted a screening and panel discussion highlighting advances in Duchenne care, clinical trials and research from UC Irvine’s Muscle Biology and Disease Research Center.

Sep 17, 2026 | Healio

FDA clears robotic Triton 1 System for diagnostic, therapeutic colonoscopy

The robotic endoscopy Triton 1 System, tested in a clinical trial led by UC Irvine Professor Jason Samarasena, MD, has received FDA clearance for use in diagnostic and therapeutic procedures of the colon.